. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2015 Oct 8;54(12):999–1007.e4. doi: 10.1016/j.jaac.2015.09.016

Table 1.

Discontinuation Rates by Reason and Medication^a

	Total (24.7%; 69/279)	Risperidone (15.7%; 14/89)	Lithium (32.2%; 29/90)	Divalproex Sodium (26.0%; 26/100)
Reasons for Discontinuation, n (%)
Changed Mind	37/69 (53.6)	8/14 (57.8)	15/29 (51.7)	14/26 (53.8)
Side effects	15/69 (21.7)	3/14 (21.4)	8/29 (27.6)	4/26 (15.4)
Worsening of Symptoms	7/69 (10.1)	0/14 (0)	4/29 (13.8)	3/26 (11.5)
Psychiatric Hospitalization	4/69 (5.8)	1/14 (7.1)	1/29 (3.4)	2/26 (7.7)
Geographical relocation	1/69 (1.4)	0/14 (0)	0/29 (0)	1/26 (3.8)
Onset of severe medical illness	1/69 (1.4)	0/14 (0)	0/29 (0)	1/26 (3.8)
Weight/BMI increase	1/69 (1.4)	1/14 (7.1)	0/29 (0)	0/26 (0)
Other	3/69 (4.3)	1/14 (7.1)	1/29 (3.4)	1/26 (3.8)

Note: BMI = body mass index

Adapted from Geller et al.¹⁶, eTable 1.